DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

AnaptysBio Q4 EPS $(0.75) Beats $(1.20) Estimate, Sales $3M Beat $2M Estimate

AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(1.2) by 37.5 percent. This is a 17.19 percent decrease over losses of $(0.64) per share from the same

Benzinga · 03/02/2020 13:46

AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(1.2) by 37.5 percent. This is a 17.19 percent decrease over losses of $(0.64) per share from the same period last year. The company reported quarterly sales of $3 million which beat the analyst consensus estimate of $2 million by 50.00 percent.